Announced
Completed
KKR-backed Alcon completed the acquisition of a majority stake in Aurion Biotech for $99m.
Synopsis
KKR-backed Alcon, a manufacturer of eye care products, completed the acquisition of a majority stake in Aurion Biotech, a clinical-stage biotech company, for $99m.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite